Expression of preproNPY and precursor VIP mRNAs in rats under hypo- or hyperthyroid conditions

Linda Huffman, Mieczyslaw Michalkiewicz, Kent E. Vrana, George A. Hedge

Research output: Contribution to journalArticle

8 Citations (Scopus)

Abstract

Both neuropeptide Y (NPY) and vasoactive intestinal peptide (VIP) are present in thyroid nerves and have been shown to alter thyroid activity. The present study was conducted to determine whether hypo- or hyperthyroidism is associated with changes in the expression of the mRNAs for these neuropeptides in the major ganglia which supply nerves to the thyroid or within the thyroid gland itself. Hypo- or hyperthyroid conditions were induced by the administration of propylthiouracil (PTU) or thyroxine (T4), respectively, for 6 days. Control rats received vehicle injections. Total RNA from superior cervical ganglia (SCG), local thyroid ganglia, thyroid gland, and selected other tissues was extracted and mRNA levels were analyzed using Northern blot procedures. No significant changes in preproNPY or precursor VIP mRNA levels were detected in the SCG or the local thyroid ganglia in response to PTU or T4 treatment. However, PTU treatment was associated with an increase in preproNPY mRNA levels in the thyroid gland itself. These results indicate that changes within the thyroid axis in response to these hypo- and hyperthyroid conditions do not include alterations in steady-state preproNPY or precursor VIP mRNA concentrations in the major ganglia which supply nerves to the thyroid gland. However, intrathyroidal preproNPY mRNA levels are increased as a consequence of the thyroidal adaptation to a PTU challenge.

Original languageEnglish (US)
Pages (from-to)418-424
Number of pages7
JournalMolecular and Cellular Neuroscience
Volume3
Issue number5
DOIs
StatePublished - Oct 1992

Fingerprint

Hyperthyroidism
Thyroid Gland
Messenger RNA
Propylthiouracil
Ganglia
Superior Cervical Ganglion
vasoactive intestinal peptide precursor
Neuropeptide Y
Vasoactive Intestinal Peptide
Hypothyroidism
Neuropeptides
Thyroxine
Northern Blotting
RNA
Injections

All Science Journal Classification (ASJC) codes

  • Molecular Biology
  • Cellular and Molecular Neuroscience
  • Cell Biology

Cite this

Huffman, Linda ; Michalkiewicz, Mieczyslaw ; Vrana, Kent E. ; Hedge, George A. / Expression of preproNPY and precursor VIP mRNAs in rats under hypo- or hyperthyroid conditions. In: Molecular and Cellular Neuroscience. 1992 ; Vol. 3, No. 5. pp. 418-424.
@article{d9698ef2e60145a8a3f3758ad51ae06b,
title = "Expression of preproNPY and precursor VIP mRNAs in rats under hypo- or hyperthyroid conditions",
abstract = "Both neuropeptide Y (NPY) and vasoactive intestinal peptide (VIP) are present in thyroid nerves and have been shown to alter thyroid activity. The present study was conducted to determine whether hypo- or hyperthyroidism is associated with changes in the expression of the mRNAs for these neuropeptides in the major ganglia which supply nerves to the thyroid or within the thyroid gland itself. Hypo- or hyperthyroid conditions were induced by the administration of propylthiouracil (PTU) or thyroxine (T4), respectively, for 6 days. Control rats received vehicle injections. Total RNA from superior cervical ganglia (SCG), local thyroid ganglia, thyroid gland, and selected other tissues was extracted and mRNA levels were analyzed using Northern blot procedures. No significant changes in preproNPY or precursor VIP mRNA levels were detected in the SCG or the local thyroid ganglia in response to PTU or T4 treatment. However, PTU treatment was associated with an increase in preproNPY mRNA levels in the thyroid gland itself. These results indicate that changes within the thyroid axis in response to these hypo- and hyperthyroid conditions do not include alterations in steady-state preproNPY or precursor VIP mRNA concentrations in the major ganglia which supply nerves to the thyroid gland. However, intrathyroidal preproNPY mRNA levels are increased as a consequence of the thyroidal adaptation to a PTU challenge.",
author = "Linda Huffman and Mieczyslaw Michalkiewicz and Vrana, {Kent E.} and Hedge, {George A.}",
year = "1992",
month = "10",
doi = "10.1016/1044-7431(92)90053-5",
language = "English (US)",
volume = "3",
pages = "418--424",
journal = "Molecular and Cellular Neurosciences",
issn = "1044-7431",
publisher = "Academic Press Inc.",
number = "5",

}

Expression of preproNPY and precursor VIP mRNAs in rats under hypo- or hyperthyroid conditions. / Huffman, Linda; Michalkiewicz, Mieczyslaw; Vrana, Kent E.; Hedge, George A.

In: Molecular and Cellular Neuroscience, Vol. 3, No. 5, 10.1992, p. 418-424.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Expression of preproNPY and precursor VIP mRNAs in rats under hypo- or hyperthyroid conditions

AU - Huffman, Linda

AU - Michalkiewicz, Mieczyslaw

AU - Vrana, Kent E.

AU - Hedge, George A.

PY - 1992/10

Y1 - 1992/10

N2 - Both neuropeptide Y (NPY) and vasoactive intestinal peptide (VIP) are present in thyroid nerves and have been shown to alter thyroid activity. The present study was conducted to determine whether hypo- or hyperthyroidism is associated with changes in the expression of the mRNAs for these neuropeptides in the major ganglia which supply nerves to the thyroid or within the thyroid gland itself. Hypo- or hyperthyroid conditions were induced by the administration of propylthiouracil (PTU) or thyroxine (T4), respectively, for 6 days. Control rats received vehicle injections. Total RNA from superior cervical ganglia (SCG), local thyroid ganglia, thyroid gland, and selected other tissues was extracted and mRNA levels were analyzed using Northern blot procedures. No significant changes in preproNPY or precursor VIP mRNA levels were detected in the SCG or the local thyroid ganglia in response to PTU or T4 treatment. However, PTU treatment was associated with an increase in preproNPY mRNA levels in the thyroid gland itself. These results indicate that changes within the thyroid axis in response to these hypo- and hyperthyroid conditions do not include alterations in steady-state preproNPY or precursor VIP mRNA concentrations in the major ganglia which supply nerves to the thyroid gland. However, intrathyroidal preproNPY mRNA levels are increased as a consequence of the thyroidal adaptation to a PTU challenge.

AB - Both neuropeptide Y (NPY) and vasoactive intestinal peptide (VIP) are present in thyroid nerves and have been shown to alter thyroid activity. The present study was conducted to determine whether hypo- or hyperthyroidism is associated with changes in the expression of the mRNAs for these neuropeptides in the major ganglia which supply nerves to the thyroid or within the thyroid gland itself. Hypo- or hyperthyroid conditions were induced by the administration of propylthiouracil (PTU) or thyroxine (T4), respectively, for 6 days. Control rats received vehicle injections. Total RNA from superior cervical ganglia (SCG), local thyroid ganglia, thyroid gland, and selected other tissues was extracted and mRNA levels were analyzed using Northern blot procedures. No significant changes in preproNPY or precursor VIP mRNA levels were detected in the SCG or the local thyroid ganglia in response to PTU or T4 treatment. However, PTU treatment was associated with an increase in preproNPY mRNA levels in the thyroid gland itself. These results indicate that changes within the thyroid axis in response to these hypo- and hyperthyroid conditions do not include alterations in steady-state preproNPY or precursor VIP mRNA concentrations in the major ganglia which supply nerves to the thyroid gland. However, intrathyroidal preproNPY mRNA levels are increased as a consequence of the thyroidal adaptation to a PTU challenge.

UR - http://www.scopus.com/inward/record.url?scp=0026761327&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0026761327&partnerID=8YFLogxK

U2 - 10.1016/1044-7431(92)90053-5

DO - 10.1016/1044-7431(92)90053-5

M3 - Article

AN - SCOPUS:0026761327

VL - 3

SP - 418

EP - 424

JO - Molecular and Cellular Neurosciences

JF - Molecular and Cellular Neurosciences

SN - 1044-7431

IS - 5

ER -